Cardinal Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Cardinal Capital Management, Inc.

$2.18 Billion
Q3 2024

A detailed history of Cardinal Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cardinal Capital Management, Inc. holds 20,248 shares of GILD stock, worth $1.83 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

20,248

Previous 190,383 89.36%

Holding current value

$1.83 Million

Previous $13.1 Million 87.01%

% of portfolio

0.08%

Previous 0.61%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$66.59 - $83.99 $11.3 Million - $14.3 Million	-170,135 Reduced 89.36%	20,248 $1.7 Million
Q2 2024 Jul 08, 2024	BUY	$63.15 - $72.88 $73,443 - $84,759	1,163 Added 0.61%	190,383 $13.1 Million
Q1 2024 Apr 09, 2024	BUY	$71.58 - $87.29 $639,209 - $779,499	8,930 Added 4.95%	189,220 $13.9 Million
Q4 2023 Feb 23, 2024	SELL	$73.27 - $83.09 $174,748 - $198,169	-2,385 Reduced 1.31%	180,290 $14.6 Million
Q3 2023 Oct 12, 2023	BUY	$73.94 - $80.67 $41,036 - $44,771	555 Added 0.3%	182,675 $13.7 Million
Q2 2023 Jul 10, 2023	SELL	$76.01 - $86.7 $124,276 - $141,754	-1,635 Reduced 0.89%	182,120 $14 Million
Q1 2023 Apr 06, 2023	SELL	$77.31 - $88.08 $120,217 - $136,964	-1,555 Reduced 0.84%	183,755 $15.2 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $274,831 - $394,562	4,410 Added 2.44%	185,310 $15.9 Million
Q3 2022 Oct 07, 2022	BUY	$59.54 - $68.01 $259,594 - $296,523	4,360 Added 2.47%	180,900 $11.2 Million
Q2 2022 Jul 13, 2022	SELL	$57.72 - $65.01 $5.18 Million - $5.84 Million	-89,830 Reduced 33.72%	176,540 $10.9 Million
Q1 2022 Apr 12, 2022	BUY	$57.92 - $72.58 $1.4 Million - $1.76 Million	24,230 Added 10.01%	266,370 $15.8 Million
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $1.08 Million - $1.22 Million	16,600 Added 7.36%	242,140 $17.6 Million
Q3 2021 Oct 07, 2021	BUY	$67.69 - $73.03 $565,888 - $610,530	8,360 Added 3.85%	225,540 $15.8 Million
Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $1.24 Million - $1.35 Million	19,537 Added 9.88%	217,180 $15 Million
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $2.44 Million - $2.79 Million	40,708 Added 25.94%	197,643 $12.8 Million
Q4 2020 Jan 15, 2021	BUY	$56.65 - $64.55 $701,610 - $799,451	12,385 Added 8.57%	156,935 $9.14 Million
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $1.34 Million - $1.69 Million	21,645 Added 17.61%	144,550 $9.13 Million
Q2 2020 Jul 08, 2020	BUY	$72.34 - $84.0 $1.77 Million - $2.06 Million	24,500 Added 24.9%	122,905 $9.46 Million
Q1 2020 Apr 08, 2020	BUY	$62.63 - $80.22 $6.16 Million - $7.89 Million	98,405 New	98,405 $7.36 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management, Inc. with notifications on news.

Account

Cardinal Capital Management, Inc. Gilead Sciences, Inc. Transaction History